Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
N-glycosylation of mouse TRAIL-R and human TRAIL-R1 enhances TRAIL-induced death.
Dufour F, Rattier T, Shirley S, Picarda G, Constantinescu AA, Morlé A, Zakaria AB, Marcion G, Causse S, Szegezdi E, Zajonc DM, Seigneuric R, Guichard G, Gharbi T, Picaud F, Herlem G, Garrido C, Schneider P, Benedict CA, Micheau O. Dufour F, et al. Among authors: szegezdi e. Cell Death Differ. 2017 Mar;24(3):500-510. doi: 10.1038/cdd.2016.150. Epub 2017 Feb 10. Cell Death Differ. 2017. PMID: 28186505 Free PMC article.
TRAIL receptor signalling and modulation: Are we on the right TRAIL?
Mahalingam D, Szegezdi E, Keane M, de Jong S, Samali A. Mahalingam D, et al. Among authors: szegezdi e. Cancer Treat Rev. 2009 May;35(3):280-8. doi: 10.1016/j.ctrv.2008.11.006. Epub 2008 Dec 30. Cancer Treat Rev. 2009. PMID: 19117685 Review.
Stem cells are resistant to TRAIL receptor-mediated apoptosis.
Szegezdi E, O'Reilly A, Davy Y, Vawda R, Taylor DL, Murphy M, Samali A, Mehmet H. Szegezdi E, et al. J Cell Mol Med. 2009 Nov-Dec;13(11-12):4409-14. doi: 10.1111/j.1582-4934.2008.00522.x. J Cell Mol Med. 2009. PMID: 19604313 Free PMC article.
Targeting AML through DR4 with a novel variant of rhTRAIL.
Szegezdi E, Reis CR, van der Sloot AM, Natoni A, O'Reilly A, Reeve J, Cool RH, O'Dwyer M, Knapper S, Serrano L, Quax WJ, Samali A. Szegezdi E, et al. J Cell Mol Med. 2011 Oct;15(10):2216-31. doi: 10.1111/j.1582-4934.2010.01211.x. J Cell Mol Med. 2011. PMID: 21070598 Free PMC article.
Kinetics in signal transduction pathways involving promiscuous oligomerizing receptors can be determined by receptor specificity: apoptosis induction by TRAIL.
Szegezdi E, van der Sloot AM, Mahalingam D, O'Leary L, Cool RH, Muñoz IG, Montoya G, Quax WJ, de Jong S, Samali A, Serrano L. Szegezdi E, et al. Mol Cell Proteomics. 2012 Mar;11(3):M111.013730. doi: 10.1074/mcp.M111.013730. Epub 2012 Jan 2. Mol Cell Proteomics. 2012. PMID: 22213832 Free PMC article.
TRAIL receptor gene editing unveils TRAIL-R1 as a master player of apoptosis induced by TRAIL and ER stress.
Dufour F, Rattier T, Constantinescu AA, Zischler L, Morlé A, Ben Mabrouk H, Humblin E, Jacquemin G, Szegezdi E, Delacote F, Marrakchi N, Guichard G, Pellat-Deceunynck C, Vacher P, Legembre P, Garrido C, Micheau O. Dufour F, et al. Among authors: szegezdi e. Oncotarget. 2017 Feb 7;8(6):9974-9985. doi: 10.18632/oncotarget.14285. Oncotarget. 2017. PMID: 28039489 Free PMC article.
76 results